BETA-ADRENERGIC BLOCKERS

被引:73
作者
FRISHMAN, WH [1 ]
机构
[1] YESHIVA UNIV ALBERT EINSTEIN COLL MED, BRONX, NY 10461 USA
关键词
D O I
10.1016/S0025-7125(16)30786-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:37 / 81
页数:45
相关论文
共 214 条
[51]  
FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707
[52]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .3. COMPARATIVE CLINICAL-EXPERIENCE AND NEW THERAPEUTIC APPLICATIONS [J].
FRISHMAN, W ;
SILVERMAN, R .
AMERICAN HEART JOURNAL, 1979, 98 (01) :119-131
[53]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .8. SELF-POISONING WITH BETA-ADRENOCEPTOR BLOCKING-AGENTS - RECOGNITION AND MANAGEMENT [J].
FRISHMAN, W ;
JACOB, H ;
EISENBERG, E ;
RIBNER, H .
AMERICAN HEART JOURNAL, 1979, 98 (06) :798-811
[54]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .7. NEW HORIZONS IN BETA-ADRENOCEPTOR BLOCKADE THERAPY - LABETALOL [J].
FRISHMAN, W ;
HALPRIN, S .
AMERICAN HEART JOURNAL, 1979, 98 (05) :660-665
[55]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .6. COMPARISON OF PINDOLOL AND PROPRANOLOL IN TREATMENT OF PATIENTS WITH ANGINA-PECTORIS - ROLE OF INTRINSIC SYMPATHOMIMETIC ACTIVITY [J].
FRISHMAN, W ;
KOSTIS, J ;
STROM, J ;
HOSSLER, M ;
ELKAYAM, U ;
GOLDNER, S ;
SILVERMAN, R ;
DAVIS, R ;
WEINSTEIN, J ;
SONNENBLICK, E .
AMERICAN HEART JOURNAL, 1979, 98 (04) :526-535
[57]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .4. ADVERSE-EFFECTS - CHOOSING A BETA-ADRENORECEPTOR BLOCKER [J].
FRISHMAN, W ;
SILVERMAN, R ;
STROM, J ;
ELKAYAM, U ;
SONNENBLICK, E .
AMERICAN HEART JOURNAL, 1979, 98 (02) :256-262
[59]  
FRISHMAN W, 1985, CARDIOVASC REV REP, V6, P979
[60]   THE BETA-ADRENOCEPTOR BLOCKING-DRUGS [J].
FRISHMAN, WH .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1982, 2 (02) :165-178